Jack A. Khattar

Companies

• COGNITION THERAPEUTICS INCBoard member Oct 7, 2021 to now¹
• scPharmaceuticals (United States)Board member Nov 16, 2017 to now²
• SUPERNUS PHARMACEUTICALS, INC.Board member Apr 30, 2012 to now³
• SUPERNUS PHARMACEUTICALS, INC.Chief executive officer Apr 30, 2012 to now³
• SUPERNUS PHARMACEUTICALS, INC.President Apr 30, 2012 to Aug 24, 2021³
• TesaroBoard member Mar 30, 2016 to Mar 30, 2016⁴
• TesaroChief executive officer Mar 30, 2016 to Mar 30, 2016⁴
• TesaroPresident Mar 30, 2016 to Mar 30, 2016⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• SPSUPERNUS PHARMACEUTICALS, INC. SUPN2,216,451 shares⁵$88.5M at $39.91Aug 14, 2026
• CTCOGNITION THERAPEUTICS INC CGTX73,500 shares⁶$53.6K at $0.73Jun 17, 2026
• SUscPharmaceuticals (United States)0 shares⁷Oct 7, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 12, 2026Shares withheld for tax 12,642 shares at $46.57 of SUPERNUS PHARMACEUTICALS, INC.⁵
• Aug 12, 2026Exercised options 29,849 shares of SUPERNUS PHARMACEUTICALS, INC.⁵
• Jun 17, 2026Granted 25,000 shares of COGNITION THERAPEUTICS INC⁶
• Mar 13, 2026Sold 120 shares at $51.75 of SUPERNUS PHARMACEUTICALS, INC.⁸
• Mar 13, 2026Sold 10,742 shares at $51.00 of SUPERNUS PHARMACEUTICALS, INC.⁸
• Mar 13, 2026Sold 24,138 shares at $50.09 of SUPERNUS PHARMACEUTICALS, INC.⁸
• Mar 13, 2026Other 12,500 shares of SUPERNUS PHARMACEUTICALS, INC.⁸
• Mar 13, 2026Other 12,500 shares of SUPERNUS PHARMACEUTICALS, INC.⁸
• Mar 6, 2026Shares withheld for tax 16,574 shares at $54.73 of SUPERNUS PHARMACEUTICALS, INC.⁹
• Mar 6, 2026Exercised options 38,640 shares of SUPERNUS PHARMACEUTICALS, INC.⁹
• Oct 9, 2025Sold 1,529 shares at $51.46 of SUPERNUS PHARMACEUTICALS, INC.¹⁰
• Oct 9, 2025Sold 58,371 shares at $50.55 of SUPERNUS PHARMACEUTICALS, INC.¹⁰
• Oct 9, 2025Exercised options 81,250 shares at $25.30 of SUPERNUS PHARMACEUTICALS, INC.¹⁰
• Oct 7, 2025U 5,000 shares of scPharmaceuticals (United States)⁷
• Oct 2, 2025Shares withheld for tax 7,529 shares at $46.21 of SUPERNUS PHARMACEUTICALS, INC.¹¹
• Oct 2, 2025Exercised options 19,320 shares of SUPERNUS PHARMACEUTICALS, INC.¹¹
• Oct 2, 2025Shares withheld for tax 7,796 shares at $46.21 of SUPERNUS PHARMACEUTICALS, INC.¹¹
• Oct 2, 2025Sold 1,904 shares at $48.06 of SUPERNUS PHARMACEUTICALS, INC.¹²
• Oct 2, 2025Exercised options 20,000 shares of SUPERNUS PHARMACEUTICALS, INC.¹¹
• Oct 2, 2025Exercised options 2,267 shares at $25.30 of SUPERNUS PHARMACEUTICALS, INC.¹²
• Oct 1, 2025Sold 40,173 shares at $48.07 of SUPERNUS PHARMACEUTICALS, INC.¹³
• Oct 1, 2025Exercised options 53,785 shares at $25.30 of SUPERNUS PHARMACEUTICALS, INC.¹³
• Sep 30, 2025Sold 8,588 shares at $48.25 of SUPERNUS PHARMACEUTICALS, INC.¹⁴
• Sep 30, 2025Exercised options 11,510 shares at $25.30 of SUPERNUS PHARMACEUTICALS, INC.¹⁴
• Sep 29, 2025Sold 10,235 shares at $48.02 of SUPERNUS PHARMACEUTICALS, INC.¹⁵